KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Invested Capital (2017 - 2025)

Twist Bioscience (TWST) has disclosed Invested Capital for 7 consecutive years, with $657.6 million as the latest value for Q2 2023.

  • On a quarterly basis, Invested Capital fell 19.88% to $657.6 million in Q2 2023 year-over-year; TTM through Jun 2023 was $657.6 million, a 19.88% decrease, with the full-year FY2022 number at $789.4 million, up 35.55% from a year prior.
  • Invested Capital was $657.6 million for Q2 2023 at Twist Bioscience, down from $703.9 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $863.4 million in Q1 2022 to a low of $106.4 million in Q4 2019.
  • A 5-year average of $510.8 million and a median of $615.1 million in 2021 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: decreased 25.02% in 2019, then soared 502.63% in 2020.
  • Twist Bioscience's Invested Capital stood at $106.4 million in 2019, then skyrocketed by 502.63% to $641.3 million in 2020, then dropped by 0.94% to $635.3 million in 2021, then increased by 17.48% to $746.3 million in 2022, then fell by 11.89% to $657.6 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Invested Capital are $657.6 million (Q2 2023), $703.9 million (Q1 2023), and $746.3 million (Q4 2022).